Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Diluted EPS Excl. Extra Items

Apellis Pharmaceuticals Inc Diluted EPS Excl. Extra Items Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Diluted EPS Excl. Extra Items from 2017 to 2018. Earnings per share (EPS) is the portion of a company's profit allocated to each outstanding share of common stock. Earnings per share serves as an indicator of a company's profitability. EPS is calculated as: EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.
  • Apellis Pharmaceuticals Inc Diluted EPS Excl. Extra Items for the quarter ending December 12, 2018 was $-1m a 33.37% decrease of 0m year over year
  • Apellis Pharmaceuticals Inc Diluted EPS Excl. Extra Items for the last 12 months ending December 12, 2018 was $-2m a -11.58% increase of 0m year over year
  • Apellis Pharmaceuticals Inc Annual Diluted EPS Excl. Extra Items for 2018 was $-2m a -56.88% increase of 1m from 2017
  • Apellis Pharmaceuticals Inc Annual Diluted EPS Excl. Extra Items for 2017 was $-4m a 12.48% decrease of 0m from 2016
  • Apellis Pharmaceuticals Inc Annual Diluted EPS Excl. Extra Items for 2016 was $-3m a -149.42% increase of 5m from 2015
Other Per Share Metrics:
  • Apellis Pharmaceuticals Inc Diluted EPS Incl. Extra Items for the quarter ending December 12, 2018 was $-1m a 33.37% decrease of 0m year over year
View Chart On Koyfin

Quarterly APLS Diluted EPS Excl. Extra Items Data

12/2018$-1m
09/2018$-1m
06/2018$-1m
03/2018$0m
12/2017$-1m
09/2017$-1m
06/2017$-1m
03/2017$-1m

Annual APLS Diluted EPS Excl. Extra Items Data

2018$-2m
2017$-4m
2016$-3m
2015$-8m